biospecimen_aliquot__bcr_aliquot_barcode	tcga-d8-a3z6-01a-11d-a23c-09
biospecimen_aliquot__bcr_aliquot_uuid	67a233d6-6e32-4224-a9af-c5579672d155
biospecimen_aliquot__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_aliquot__bcr_sample_barcode	tcga-d8-a3z6-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0132260850
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2012-07-31
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	2
biospecimen_aliquot__plate_id	a23c
biospecimen_aliquot__plate_row	g
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-d8-a3z6-01a-11d
biospecimen_analyte__bcr_analyte_uuid	9db64d27-f52d-4b4b-a5cf-82a2bc408f42
biospecimen_analyte__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_analyte__bcr_sample_barcode	tcga-d8-a3z6-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-d8-a3z6
biospecimen_diagnostic_slides__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-d8-a3z6-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	4076a770-5901-4325-85c3-af7b192272f5
biospecimen_normal_control__bcr_patient_barcode	tcga-d8-a3z6
biospecimen_normal_control__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_portion__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_portion__bcr_portion_barcode	tcga-d8-a3z6-01a-11
biospecimen_portion__bcr_portion_uuid	199a9b70-91d0-47a8-88ae-cb81d6b070ee
biospecimen_portion__bcr_sample_barcode	tcga-d8-a3z6-01a
biospecimen_portion__date_of_creation	2012-06-26
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-d8-a3z6-01a-11d
biospecimen_protocol__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_protocol__bcr_sample_barcode	tcga-d8-a3z6-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_sample__bcr_sample_barcode	tcga-d8-a3z6-01a
biospecimen_sample__bcr_sample_uuid	287b037a-c32a-49f0-bed6-7674d2e26574
biospecimen_sample__days_to_collection	160
biospecimen_sample__initial_weight	60
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-d8-a3z6.a8f63d86-37df-472e-af29-fb734eab7e5c.pdf
biospecimen_sample__pathology_report_uuid	a8f63d86-37df-472e-af29-fb734eab7e5c
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
biospecimen_slide__bcr_sample_barcode	tcga-d8-a3z6-01a
biospecimen_slide__bcr_slide_barcode	tcga-d8-a3z6-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	9cc3d75e-69d3-4dc0-b541-753ee41aeb22
biospecimen_slide__image_file_name	tcga-d8-a3z6-01a-01-ts1.9cc3d75e-69d3-4dc0-b541-753ee41aeb22.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	2
biospecimen_slide__percent_monocyte_infiltration	1
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	0
biospecimen_slide__percent_tumor_cells	100
biospecimen_slide__percent_tumor_nuclei	75
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-d8-a3z6
biospecimen_tumor_sample__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
clinical_drug__bcr_drug_barcode	tcga-d8-a3z6-d59241
clinical_drug__bcr_drug_uuid	25adcd91-c55b-445c-8b2d-4008d97434ae
clinical_drug__bcr_patient_barcode	tcga-d8-a3z6
clinical_drug__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
clinical_drug__form_completion_date	2014-5-6
clinical_drug__pharmaceutical_therapy_drug_name	doxorubicinum
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	86
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	22
clinical_drug__treatment_best_response	stable disease
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-d8-a3z6-f51367
clinical_follow_up__bcr_followup_uuid	9dd39b06-7d2b-4656-9c5f-90aaa50d3a64
clinical_follow_up__bcr_patient_barcode	tcga-d8-a3z6
clinical_follow_up__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2013-11-18
clinical_follow_up__last_contact_days_to	563
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	56
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n3a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiic
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t3
clinical_patient__anatomic_neoplasm_subdivision	left
clinical_patient__axillary_staging_method	other (specify)
clinical_patient__axillary_staging_method_other	mastectomy with tlnd
clinical_patient__bcr_patient_barcode	tcga-d8-a3z6
clinical_patient__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
clinical_patient__birth_days_to	-20629
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2012-7-3
clinical_patient__gender	female
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	185
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	22
clinical_patient__lymph_nodes_examined_he_count	19
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a3z6
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	d8
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-d8-a3z6
clinical_radiation__bcr_patient_uuid	a6e5f869-1182-4f81-b4bb-cf55261c8f3f
clinical_radiation__bcr_radiation_barcode	tcga-d8-a3z6-r51369
clinical_radiation__bcr_radiation_uuid	7be92c39-4eed-4e33-85eb-996f80fec082
clinical_radiation__form_completion_date	2013-11-18
clinical_radiation__radiation_adjuvant_fractions_total	22
clinical_radiation__radiation_adjuvant_units	gy
clinical_radiation__radiation_therapy_ended_days_to	260
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	234
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	45
clinical_radiation__treatment_best_response	stable disease
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A3Z6-01A-11D-A23C-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A3Z6-01A-11D-A23C-09.bed.meta
manually_curated__id	tcga-d8-a3z6-01a-11d-a23c-09
manually_curated__md5sum	04f084c336d2cd10b4928e80d65bfe3b
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	67a233d6-6e32-4224-a9af-c5579672d155
manually_curated__tumor_tag	brca
